Yes, Gilenya Is a Pill
Gilenya (fingolimod) is an oral capsule taken once daily by mouth, making it a pill form of medication.[1] Patients swallow it whole with water, typically at the same time each day, with or without food.
How Do You Take Gilenya?
Start with a 0.5 mg dose after monitoring heart rate for 6 hours on the first day due to potential bradycardia risks. Maintenance is 0.5 mg daily for adults and 0.25 mg for children 10+ years old with relapsing multiple sclerosis (MS).[1][2] No injections or infusions needed, unlike some MS treatments.
Why Choose Gilenya over Injectables Like Avonex or Tysabri?
Gilenya avoids needles, improving convenience for long-term MS management. It traps immune cells in lymph nodes to reduce brain inflammation, approved by FDA in 2010 as the first oral MS therapy.[2] Common alternatives like interferon betas require weekly injections.
What Happens If You Miss a Dose?
Take it as soon as remembered unless close to the next dose—then skip and resume schedule. Stopping abruptly needs doctor guidance to monitor for MS relapse or rebound activity.[1]
Common Side Effects Patients Report
Headache, back pain, high blood pressure, and infections top lists. Serious risks include slowed heart rate, vision issues (macular edema), and increased infection susceptibility—requires eye exams and vaccinations beforehand.[2] Liver enzyme monitoring is standard.
When Does Gilenya's Patent Expire?
Key U.S. patents expired in 2019, allowing generics like fingolimod from Teva and others to launch, dropping costs significantly.[3] Original brand from Novartis.
[1] Gilenya.com (official prescribing info)
[2] FDA.gov (Gilenya label)
[3] DrugPatentWatch.com